Safety and tolerability of molnupiravir and nirmatrelvir/ritonavir in patients with advanced chronic kidney disease and kidney failure; a cohort study.

• Tác giả: Sherley M Mejia, Daiana Moreno, Tianqi Ouyang, Rani Sawtell, Meghan E Sise, Ian Strohbehn
• Ngôn ngữ: eng
• Ký hiệu phân loại: 069.50289 Collections and exhibits of museum objects
• Thông tin xuất bản: England : Renal failure , 2025
• Bộ sưu tập: NCBI
• ID: 469627

Tóm tắt

Patients with advanced chronic kidney disease (CKD) and kidney failure were excluded from clinical trials that led to approval of molnupiravir and nirmatrelvir/ritonavir for COVID-19. Between November 2022 and February 2024 there were 100 patients with advanced CKD (